Study of COVID-19 patients, as well as in vitro and in vivo studies, showed that S-proteins induced ACE2-mediated endothelial activation, endothelial injury, oxidative stress, and inflammation, associated with increased platelets aggregation [21,23,39]. Here, PROS1 is linked to COVID-19.